查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1702242

2025 年至 2033 年α發射體市場規模、佔有率、趨勢及預測（按放射性核種類型、醫療應用、最終用戶和地區分類）

Alpha Emitter Market Size, Share, Trends and Forecast by Type of Radionuclide, Medical Application, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球 α 發射體市場規模價值 18.3448 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 120.402 億美元，2025 年至 2033 年的複合年成長率為 23.25%。北美目前佔據市場主導地位，到 2024 年其市佔率將超過 43.7%。對標靶癌症治療的關注度不斷提高，以及新核子醫學產品獲批數量的不斷增加等因素，正在增強 α 發射體的市場佔有率。

阿爾法發射體是由放射源發射的物質，在釋放阿爾法粒子後會衰變。它們實現適當的生物分佈和相關的劑量分佈，以實現有效的治療，而不會引起不可接受的急性或長期副作用。由於具有極高的細胞殺傷率，在醫療過程中使用時，α粒子對腫瘤細胞的破壞性比BETA粒子更大。因此，它們對鄰近正常組織的損害較小。鐳、鉛和鉍是治療過程中使用的一些放射性核種。阿爾法粒子的短射程和高線性能量傳輸 (LET) 使其在醫學研究中具有極大的吸引力，尤其是作為一種可行的癌症治療方法。許多類型的癌症可以用α發射體治療，包括卵巢癌、胰臟癌、淋巴瘤和黑色素瘤。

α發射體市場趨勢：

該市場主要受到癌症治療領域廣泛而高階的研究與開發 (R&D) 活動的推動。這可以歸因於人們對靶向阿爾法發射體的細胞殺傷能力的認知不斷提高。同時，各類癌症在人群中的發生率不斷上升，為市場提供了推動力。此外，老年人口的不斷增加，更容易患上多種心臟病和癌症，這為市場帶來了積極的前景。此外，醫療機構擴大採用標靶抗癌療法或阿爾法療法 (TAT) 來治療癌症，這對市場產生了積極影響。技術的不斷進步和越來越多的新型核醫學產品獲批進一步推動了市場的發展。其他影響市場發展的因素包括快速城市化、醫療基礎設施的不斷改善、醫療支出的增加以及個人可支配收入水準的提高。

本報告回答的關鍵問題

  • 阿爾法發射體市場有多大？阿爾法發射體市場的未來前景如何？
  • 推動阿爾法發射體市場發展的關鍵因素有哪些？
  • 哪個地區佔據最大的阿爾法發射體市場佔有率？
  • 全球阿爾法發射體市場領先的公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球α發射體市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依放射性核種類型

  • 砈
  • 鐳
  • 錕
  • 帶領
  • 鉍
  • 其他

第7章：市場區隔：依醫療應用

  • 攝護腺癌
  • 骨轉移
  • 卵巢癌
  • 胰腺癌
  • 內分泌腫瘤
  • 其他

第8章：市場區隔：按最終用戶

  • 醫院
  • 醫學研究機構
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Actinium Pharmaceuticals Inc.
    • Alpha Tau Medical Ltd.
    • Bayer AG
    • Fusion Pharmaceuticals
    • IBA RadioPharma Solutions
    • RadioMedix Inc.
Product Code: SR112025A6398

The global alpha emitter market size was valued at USD 1,834.48 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 12,040.20 Million by 2033, exhibiting a CAGR of 23.25% from 2025-2033. North America currently dominates the market, holding a market share of over 43.7% in 2024. Factors such as the increasing focus on targeted cancer treatments, along with the rising number of new nuclear-medicine-based product approvals, are bolstering the alpha emitter market share.

Alpha emitters are substances emitted by radioactive sources that decay after releasing alpha particles. They achieve appropriate biodistribution and associated dose distribution to achieve effective therapy without causing unacceptable acute or long-term side effects. With their exceptionally high cell-killing rates, alpha particles are more destructive to tumor cells than beta particles when used in medical procedures. Consequently, they cause less damage to adjacent normal tissues. Radium, lead and bismuth are some of the radionuclides used in the treatment process. The short range and high linear energy transfer (LET) of alpha particles have made them remarkably appealing to medical research, particularly as a viable treatment method for cancer. There are numerous types of cancer that can be treated with alpha emitters, including ovarian cancer, pancreatic cancer, lymphoma, and melanoma.

Alpha Emitter Market Trends:

The market is majorly driven by extensive and high-end research and development (R&D) activities being conducted in cancer treatment. This can be attributed to the growing awareness regarding the cell-killing abilities of targeted alpha emitters. In line with this, the rising prevalence of various types of cancer among the masses is providing an impetus to the market. Also, the increasing geriatric population that is susceptible to develop numerous cardiac and cancer ailments is creating a positive outlook for the market. Moreover, the rising adoption of targeted anticancer or alpha therapy (TAT) in healthcare facilities is impacting the market positively. The market is further propelled by continual technological advancements and the growing number of new nuclear-medicine-based product approvals. Some of the other factors contributing to the market include rapid urbanization, continual improvements in healthcare infrastructure, rising medical expenditure and inflating disposable income levels of the individuals.

Key Market Segmentation:

Breakup by Type of Radionuclide:

  • Astatine
  • Radium
  • Actinium
  • Lead
  • Bismuth
  • Others

Breakup by Medical Application:

  • Prostate Cancer
  • Bone Metastasis
  • Ovarian Cancer
  • Pancreatic Cancer
  • Endocrine Tumors
  • Others

Breakup by End User:

  • Hospitals
  • Medical Research Institutions
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Actinium Pharmaceuticals Inc., Alpha Tau Medical Ltd., Bayer AG, Fusion Pharmaceuticals, IBA RadioPharma Solutions and RadioMedix Inc.

Key Questions Answered in This Report

  • 1.How big is the alpha emitter market?
  • 2.What is the future outlook of alpha emitter market?
  • 3.What are the key factors driving the alpha emitter market?
  • 4.Which region accounts for the largest alpha emitter market share?
  • 5.Which are the leading companies in the global alpha emitter market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Alpha Emitter Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type of Radionuclide

  • 6.1 Astatine
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Radium
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Actinium
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Lead
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Bismuth
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Medical Application

  • 7.1 Prostate Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bone Metastasis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ovarian Cancer
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pancreatic Cancer
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Endocrine Tumors
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Medical Research Institutions
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Actinium Pharmaceuticals Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Alpha Tau Medical Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bayer AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Fusion Pharmaceuticals
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 IBA RadioPharma Solutions
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 RadioMedix Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio

List of Figures

  • Figure 1: Global: Alpha Emitter Market: Major Drivers and Challenges
  • Figure 2: Global: Alpha Emitter Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Alpha Emitter Market: Breakup by Type of Radionuclide (in %), 2024
  • Figure 5: Global: Alpha Emitter Market: Breakup by Medical Application (in %), 2024
  • Figure 6: Global: Alpha Emitter Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Alpha Emitter Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Alpha Emitter (Astatine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Alpha Emitter (Astatine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Alpha Emitter (Radium) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Alpha Emitter (Radium) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Alpha Emitter (Actinium) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Alpha Emitter (Actinium) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Alpha Emitter (Lead) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Alpha Emitter (Lead) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Alpha Emitter (Bismuth) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Alpha Emitter (Bismuth) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Alpha Emitter (Other Type of Radionuclides) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Alpha Emitter (Other Type of Radionuclides) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Alpha Emitter (Prostate Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Alpha Emitter (Prostate Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Alpha Emitter (Bone Metastasis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Alpha Emitter (Bone Metastasis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Alpha Emitter (Ovarian Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Alpha Emitter (Ovarian Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Alpha Emitter (Pancreatic Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Alpha Emitter (Pancreatic Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Alpha Emitter (Endocrine Tumors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Alpha Emitter (Endocrine Tumors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Alpha Emitter (Other Medical Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Alpha Emitter (Other Medical Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Alpha Emitter (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Alpha Emitter (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Alpha Emitter (Medical Research Institutions) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Alpha Emitter (Medical Research Institutions) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Alpha Emitter (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Alpha Emitter (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: North America: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: North America: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: United States: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: United States: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Canada: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Canada: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Asia-Pacific: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Asia-Pacific: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: China: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: China: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Japan: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Japan: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: India: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: India: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: South Korea: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: South Korea: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Australia: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Australia: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Indonesia: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Indonesia: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Europe: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Europe: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Germany: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Germany: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: France: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: France: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: United Kingdom: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: United Kingdom: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Italy: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Italy: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Spain: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Spain: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Russia: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Russia: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Latin America: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Latin America: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Brazil: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Brazil: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Mexico: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Mexico: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Others: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Others: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Middle East and Africa: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Middle East and Africa: Alpha Emitter Market: Breakup by Country (in %), 2024
  • Figure 86: Middle East and Africa: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Global: Alpha Emitter Industry: SWOT Analysis
  • Figure 88: Global: Alpha Emitter Industry: Value Chain Analysis
  • Figure 89: Global: Alpha Emitter Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Alpha Emitter Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Alpha Emitter Market Forecast: Breakup by Type of Radionuclide (in Million USD), 2025-2033
  • Table 3: Global: Alpha Emitter Market Forecast: Breakup by Medical Application (in Million USD), 2025-2033
  • Table 4: Global: Alpha Emitter Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Alpha Emitter Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Alpha Emitter Market: Competitive Structure
  • Table 7: Global: Alpha Emitter Market: Key Players